The effectiveness of trospium for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study.
Catheter related bladder discomfort (CRBD) is a frequent complaint after awakening from anesthesia in patients receiving perioperative bladder catheterization. Overactive bladder (OAB) and CRBD show similar symptoms, thus drugs used for management of OAB influences symptoms of CRBD. Trospium chloride has been found effective in management of resistant cases of OAB. We evaluated effectiveness of oral trospium on CRBD in the postoperative period. Sixty-four male and female adult patients were randomly divided into two groups, planned for spine surgery and requiring catheterization of urinary bladder. Group T patients received oral trospium 60 mg ER (extended-release) 1 h before induction of anesthesia and Group C patients received a similar looking placebo. Anesthesia technique was identical in both groups. CRBD score was evaluated in postop ward using 4-point scale (1 = no discomfort, 2 = mild, 3 = moderate, 4 = severe). Readings were recorded on arrival (0 h), 1 h, 2 h, and 6 h postoperatively. All patients received fentanyl for postoperative pain relief. The incidence of CRBD was significantly higher in group C than in group T at postoperative 0 h (66% vs 22%, p=0.001) and 1 h (72% vs 28%, p=0.001). The incidence of moderate to severe CRBD was higher in group C at postoperative 2 h (82% vs 14%, p=0.004). There was no significant difference in postoperative fentanyl requirements. Pretreatment with trospium 60 mg ER reduces the incidence and severity of CRBD in the early postoperative period.